Milestone MDs Bulk‑Buy Shares After FDA Nod, Signal Confidence Ahead of CARDAMYST Rollout
Milestone Pharma’s FDA‑approved CARDAMYST sparks insider buying—C‑level shares climb, signaling confidence and a shift toward revenue growth.
- Milestone Pharmaceuticals Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
5 minutes to read
